Network Topology Defines Therapeutic Vulnerability and Resistance in FLT3-Mutant Acute Myeloid Leukemia
This study demonstrates that the clinical behavior, therapeutic response, and resistance mechanisms in FLT3-mutant acute myeloid leukemia are determined by the topological architecture of gene interaction networks rather than individual mutations, with modular networks correlating to favorable outcomes and redundant, rewired networks driving resistance and relapse.